Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure
about
Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failureEvaluation and Management of Hepatic Encephalopathy: Current Status and Future DirectionsProteomic analysis of polypeptides captured from blood during extracorporeal albumin dialysis in patients with cholestasis and resistant pruritusAcute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.Three-dimensional culture of human embryonic stem cell derived hepatic endoderm and its role in bioartificial liver constructionChronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome.Acute-on-chronic Liver Failure.Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: a randomized controlled study.The end-organ impairment in liver cirrhosis: appointments for critical care.First clinical experience in 14 patients treated with ADVOS: a study on feasibility, safety and efficacy of a new type of albumin dialysis.Bench-to-bedside review: current evidence for extracorporeal albumin dialysis systems in liver failure.Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failureAcute-on-Chronic Liver Failure (ACLF) in Coastal Eastern India: "A Single-Center Experience".Survival predictors in patients treated with a molecular adsorbent recirculating systemAn Evaluation of the Usefulness of Extracorporeal Liver Support Techniques in Patients Hospitalized in the ICU for Severe Liver Dysfunction Secondary to Alcoholic Liver Disease.Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL).Acute-on-chronic liver failure: a review.Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions.Clearing of toxic substances: are there differences between the available liver support devices?Albumin dialysis: current practice and future options.Fractionated plasma separation and adsorption: current practice and future options.Artificial extracorporeal liver support therapy in patients with severe liver failure.Bench-to-beside review: acute-on-chronic liver failure - linking the gut, liver and systemic circulation.The role of molecular adsorbent recirculating system dialysis for extracorporeal liver support in children.Liver support systems: will they ever reach prime time?Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications.A stepwise approach for the management of poisoning with extracorporeal treatments.Recommendations for the management of acute hepatitis B: position paper of the Italian Society for the Study of Infectious and Tropical Diseases (SIMIT).Extracorporeal liver support in severe alcoholic hepatitis.Experience with molecular adsorbent recirculating system treatment in 20 children listed for high-urgency liver transplantation.Liver dialysis in acute-on-chronic liver failure: current and future perspectives.[Extracorporeal therapy of patients with liver disease in the intensive care unit].Development of high-efficiency molecular adsorbent recirculating system: preliminary report.Extracorporeal detoxification for hepatic failure using molecular adsorbent recirculating system: depurative efficiency and clinical results in a long-term follow-up.Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.Stability of therapeutic albumin solutions used for molecular adsorbent recirculating system-based liver dialysis.Hypoxic hepatitis: a challenging diagnosis.Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management.Hepatic encephalopathy: a critical current review.Extracorporeal liver support devices for listed patients.
P2860
Q24676985-8C4F36E8-FB3B-480C-9E61-F8E0D1C817D4Q26744689-07052222-AFFA-4486-85F0-0AC4340FCBFAQ28742619-52D361A8-BBC2-4B97-A55D-4B7E3CCB3723Q30234560-57444916-99FA-4A81-94FE-EEE91B82F1E4Q33652334-85EFCB2F-DF3D-40B0-B34C-F3C419FECD7DQ34405186-E4AF1377-59B9-4E3D-A61D-8D3F178D9C33Q34542736-8B288CBB-0850-4F60-8E7F-14B37F704BBBQ34768560-ECEBA3FB-7B02-4B27-A9CC-8D26BF3178DEQ35993701-F4BEF6E9-5675-485A-AC78-7ADE61383E65Q36283332-63D1F81F-DF4E-4290-A956-51DBC803A80DQ36392462-2AB283BF-EBB1-4AB6-9AA7-0E9C12D0599FQ36637720-25EAE71B-074D-464B-B116-7567F8D59AA0Q36886517-E2F0640C-8AEE-4548-91E8-D0D1FE4A6650Q37241955-5AF360CA-7C71-4127-B67D-5B8D99FD6C43Q37246613-89B774AB-12DE-4816-A44D-4656ED7A83CDQ37577568-62B605B0-B800-4CD2-8368-F262C7B5839AQ37729728-8F7DA726-EFE5-40EE-A6A1-2308F9830E8FQ37903856-A88C3449-4EF1-4F2C-A954-ACBD4032159BQ37913529-208360AD-C756-4575-B120-C616E22622ABQ37913530-963E9971-7390-4001-BD91-107F2CC22839Q37913532-A5F0FE7C-60DF-40C7-A60C-0171041714CAQ37930642-3F3B8E9D-2B0E-4BD0-9B7F-362C3F0E9103Q37959188-BD5B2347-5039-46C4-A480-CAE97B7E2B70Q38062342-F868B868-51A4-41FA-9C00-C8438DEACDABQ38080028-CD0AAEEF-A2B8-484A-A4E3-872D2AD3A44EQ38083035-EEBC5558-0613-44B5-9C31-135D52A3E509Q38201803-97059541-ED97-429C-8E77-75216B8A82ACQ38226627-CC90CAA6-2C95-40FB-B5A4-09AA0544C2ECQ38227837-7C140195-00B4-4566-B328-21FC15A44883Q38264667-94DA1B9A-1A45-480A-8AA0-ADE09784B41FQ38442903-EF730A8F-7EBE-4F0A-AC16-2E3090F4D5BBQ38449587-331EB275-00EE-49DA-92E5-DA8C541BA5DDQ38451211-2D590518-DC04-4AF1-BE33-BD5E1C01E706Q38453564-1C871DEB-DC2E-4C1F-B570-BE26B9676DECQ38456223-7342DA99-5E78-4DF2-BFB0-2DCD1B9EDA6FQ38461901-E1847C3E-9812-4D73-AFCA-020CD12FA8D8Q38552177-87F0CAE4-F3A1-41DF-849F-5C2DEB6C9766Q38635623-47E651DB-918B-4E8B-8ABA-2C92404DAFC3Q38645107-63C35921-2E3D-4E81-A0C0-6F15496E8ECFQ38702799-981A7B3B-2DCC-4BD2-8AF8-CE3282B59CC3
P2860
Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure
description
2006 nî lūn-bûn
@nan
2006 թուականին հրատարակուած գիտական յօդուած
@hyw
2006 թվականին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Effect of the molecular adsorb ...... hronic alcoholic liver failure
@ast
Effect of the molecular adsorb ...... hronic alcoholic liver failure
@en
Effect of the molecular adsorb ...... hronic alcoholic liver failure
@nl
type
label
Effect of the molecular adsorb ...... hronic alcoholic liver failure
@ast
Effect of the molecular adsorb ...... hronic alcoholic liver failure
@en
Effect of the molecular adsorb ...... hronic alcoholic liver failure
@nl
prefLabel
Effect of the molecular adsorb ...... hronic alcoholic liver failure
@ast
Effect of the molecular adsorb ...... hronic alcoholic liver failure
@en
Effect of the molecular adsorb ...... hronic alcoholic liver failure
@nl
P2093
P2860
P3181
P356
P1433
P1476
Effect of the molecular adsorb ...... hronic alcoholic liver failure
@en
P2093
Alexander Wilmer
Chris Verslype
Frederik Nevens
Ingrid Vander Elst
Johan Fevery
Marcel Zeegers
Pieter Evenepoel
Wim Laleman
Zahur Zaman
P2860
P2888
P3181
P356
10.1186/CC4985
P577
2006-01-01T00:00:00Z